Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention

References

• Wild S Rolic C Green A Global prevalence of diabetes: Estimates for the year 2000 and projection for 2030 Diabetes Care 2004 37 1047 1053 15111519
   PubMed Web of Science ®Google Scholar
• Mokdad AH Bowman BA Ford ES Vinicoor F Marks JS Koplan JP The continuing epidemics of obesity and diabetes in the United States JAMA 2001 286 1195 1200 11559264
   PubMed Web of Science ®Google Scholar
• Venkataraman R Nanda NC Baweja G Parikh N Bhatia V Prevalence of diabetes mellitus and related conditions in Asian Indians living in the United States Am J Cardiol 2004 94 977 980 15464696
   PubMed Web of Science ®Google Scholar
• Stumvoll M Goldstein B van Haeften T Type 2 diabetes: principles of pathogenesis and therapy Lancet 2005 365 1333 1346 15823385
   PubMed Web of Science ®Google Scholar
• Zimmet P Alberti KG Shaw J Global and societal implications of the diabetes epidemic Nature 2001 414 782 787 11742409
   PubMed Web of Science ®Google Scholar
• Alberti KG Treating type 2 diabetes–today’s targets, tomorrow’s goals Diabetes Obes Metab 2001 3 Suppl 1 S3 S10 11685827
   PubMed Web of Science ®Google Scholar
• Dandona P Aljada A Bandyopadhyay A Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol 2004 25 4 7 14698276
   PubMed Web of Science ®Google Scholar
• Dandona P Aljada A A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis Am J Cardiol 2002 90 27G 33G
   PubMed Web of Science ®Google Scholar
• Dandona P Aljada A Chaudhuri A Bandyopadhyay A The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes J Clin Endocrinol Metab 2003 88 2422 2429 12788837
   PubMed Web of Science ®Google Scholar
• Dimopoulos N Watson M Sakamoto K Hundal HS Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in raty L6 skeletal muscle cells Biochem J 2006 399 473 481 16822230
   PubMed Web of Science ®Google Scholar
• Bilan PJ Samokhvalov V Koshkina A Schertzer JD Samaan MC Klip A Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells Arch Physiol Biochem 2009 115 176 190 19671019
   PubMedGoogle Scholar
• Pickup JC Crook MA Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998 41 1241 1248 9794114
   PubMed Web of Science ®Google Scholar
• Pickup JC Matttock MB Chusney GD Burt D NIDDM as a disease of the innate immune system: association of acute phase reactants and interleukin-6 with metabolic syndrome X Diabetologia 1997 40 1286 1292 9389420
   PubMed Web of Science ®Google Scholar
• King GL The role of inflammatory cytokines in diabetes and its complications J Periodontol 2008 79 1527 1534 18673007
   PubMed Web of Science ®Google Scholar
• Larsen GL Henson PM Mediators of inflammation Annu Rev Immunol 1983 1 335 359 6399978
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS Shargill NS Spiegelman BM Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 1993 259 87 91 7678183
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS Inflammation and metabolic disorders Nature 2006 444 860 867 17167474
   PubMed Web of Science ®Google Scholar
• Beutler B Innate immunity: an overview Mol Immunol 2004 40 845 859 14698223
   PubMed Web of Science ®Google Scholar
• Takeda K Akira S TLR signaling pathways Seminars Immunol 2004 16 3 9
   PubMed Web of Science ®Google Scholar
• Le Souëf PN Gene-environmental interaction in the development of atopic asthma: new developments Curr Opin Allergy Clin Immunol 2009 9 123 127 19295429
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM Pickup JC Innate immunity, insulin resistance and type 2 diabetes Trends Endocrin Metabol 2007 19 10 16
   Web of Science ®Google Scholar
• Medzhitov R Janeway C Innate immunity N Engl J Med 2000 343 338 344 10922424
   PubMed Web of Science ®Google Scholar
• Pang C Goa Z Yin J Zhang J Jia W Ye J Macrophage infiltration into adipose tissue may promote angigenesis for adipose tissue remodeling in obesity Am J Physiol Endocrinol Metab 2008 295 E313 E322 18492768
   PubMed Web of Science ®Google Scholar
• Lumeng CN Bodzin JL Saltiel AR Obesity induces a phenotypic switch of adipose tissue macrophage polarization J Clin Invest 2007 117 175 184 17200717
   PubMed Web of Science ®Google Scholar
• Lumeng CN Deyoung SM Bodzin JL Saltiel AR Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity Diabetes 2007 56 16 23 17192460
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS Arner P Caro JF Atkinson RL Spiegelman BM Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance J Clin Invest 1995 95 2409 2415 7738205
   PubMed Web of Science ®Google Scholar
• Sjoholm A Nystrom T Inflammation and the etiology of type 2 diabetes Diabetes Metab Res Rev 2006 22 4 10 15991254
   PubMed Web of Science ®Google Scholar
• Castrillo A Joseph SB Vaidya SA Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism Mol Cell 2003 12 805 816 14580333
   PubMed Web of Science ®Google Scholar
• Wellen KE Hotamisligil GS Inflammation, stress, and diabetes J Clin Invest 2005 115 1111 1119 15864338
   PubMed Web of Science ®Google Scholar
• Shoelson SE Lee J Goldfine AB Inflammation and insulin resistance J Clin Invest 2006 116 1793 1801 16823477
   PubMed Web of Science ®Google Scholar
• Kiortsis DN Mavridis AK Vasakos S Nikas SN Drosos AA Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis Ann Rheum Dis 2005 64 765 766 15458960
   PubMed Web of Science ®Google Scholar
• Liu G Rondinone CM JNK: bridging the insulin signaling and inflammatory pathway Curr Opin Investig Drugs 2005 6 979 987
   PubMedGoogle Scholar
• Riachy R Vandewalle B Kerr CJ 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20 Endocrinology 2002 143 4809 4819 12446608
   PubMed Web of Science ®Google Scholar
• Petersen KF Dufour S Befroy D Garcia R Shulman GI Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes N Engl J Med 2004 350 664 671 14960743
   PubMed Web of Science ®Google Scholar
• Wang W Vera L Fischer WH Montminy M The CREB coactivator CRCT2 links hepatic ER stress and fasting gluconeogenesis Nature 2009 460 534 537 19543265
   PubMed Web of Science ®Google Scholar
• McCarthy MI Zeggini E Genome-wide association studies in type 2 diabetes Curr Diabetes Rep 2009 9 164 171
   PubMed Web of Science ®Google Scholar
• Krogh-Madsen R Plomgaard P Moller K Mittendorfer B Pedersen BK Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans Am J Physiol Endocrinol Metab 2006 291 E108 E114 16464907
   PubMed Web of Science ®Google Scholar
• Pradhan AD Manson JE Rifai N Buring JE Ridker PM C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 2001 286 327 334 11466099
   PubMed Web of Science ®Google Scholar
• Festa A D’Agostino RJr Tracy RP Haffner SM Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study Diabetes 2002 51 1131 1137 11916936
   PubMed Web of Science ®Google Scholar
• Meigs JB Hu FB Rifai N Manson JE Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus JAMA 2004 291 1978 1986 15113816
   PubMed Web of Science ®Google Scholar
• Thorand B Lowel H Schneider A C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984–1998 Arch Intern Med 2003 163 93 99 12523922
   PubMed Web of Science ®Google Scholar
• Thorand B Baumert J Kolb H Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002 Diabetes Care 2007 30 854 860 17392546
   PubMed Web of Science ®Google Scholar
• Pradhan AD Obesity, metabolic syndrome, and type 2 diabetes: Inflammatory basis of glucose metabolic disorders Nutr Rev 2007 65 S152 S156 18240540
   PubMed Web of Science ®Google Scholar
• Uysal KT Wiesbrock SM Marino MW Hotamisligil GS Protection from obesityinduced insulin resistance in mice lacking TNF-alpha function Nature 1997 389 610 614 9335502
   PubMed Web of Science ®Google Scholar
• Pickup JC Inflammation and activate innate immunity in the pathogenesis of type 2 diabetes Diabetes Care 2004 27 813 823 14988310
   PubMed Web of Science ®Google Scholar
• Song MJ Kim KH Yoon JM Kim JB Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes Biochem Biophys Res Commun 2006 346 739 745 16781673
   PubMed Web of Science ®Google Scholar
• Sondergaard L Homology between the mammalian liver and the Drosophila fat body Trends Genet 1993 9 193 8337758
   PubMed Web of Science ®Google Scholar
• Shi H Kokoeva MV Inouye K Tazmeli I Yin H Flier JS TLR4 links innate immunity and fatty acid-induced insulin resistance J Clin Invest 2006 116 3015 3025 17053832
   PubMed Web of Science ®Google Scholar
• Baumann H Gauldie J The acute phase response Immunol Today 1994 15 74 80 7512342
   PubMedGoogle Scholar
• Steel DM Whitehead AS The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein Immunol Today 1994 15 81 87 8155266
   PubMedGoogle Scholar
• Gabay C Kushner I Acute-phase proteins and other systemic responses to inflammation N Engl J Med 1999 340 448 454 9971870
   PubMed Web of Science ®Google Scholar
• Montecucco F Steffens S Mach F Insulin resistance: A proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability Mediators Inflamm 2008 2008 767623 18604303
   PubMed Web of Science ®Google Scholar
• Aguirre V Uchida T Yenush L Davis R White MF The c-Jun NH2- terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 J Biol Chem 2000 275 9047 9054 10722755
   PubMed Web of Science ®Google Scholar
• Summers SA Ceramides in insulin resistance and lipotoxicity Prog Lipid Res 2006 45 42 72 16445986
   PubMed Web of Science ®Google Scholar
• JeBailey L Wanono O Niu W Roessler J Rudich A Klip A Ceramideand oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells Diabetes 2007 56 394 403 17259384
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS Peraldi P Budavari A Ellis R White ME Spiegelman BM IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance Science 1996 271 665 668 8571133
   PubMed Web of Science ®Google Scholar
• Yuan M Konstantopoulos N Lee J Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ Science 2001 293 1673 1677 11533494
   PubMed Web of Science ®Google Scholar
• Morris MF Insulin receptor signalling and regulation Pickup JC Williams G Textbook of Diabetes 3rd edn Oxford, UK Blackwell 2003141 14 17
   Google Scholar
• Baud V Karin M Signal transduction by tumor necrosis factor and its relatives Trends Cell Biol 2001 11 372 377 11514191
   PubMed Web of Science ®Google Scholar
• Hu PHZ Couvillon AD Kaufman RJ Exton JH Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression Mol Cell Biol 2006 26 3071 3084 16581782
   PubMed Web of Science ®Google Scholar
• Nguyen MT Favelyukis S Nguyen AK A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways J Biol Chem 2007 282 35279 35292 17916553
   PubMed Web of Science ®Google Scholar
• Zahng Y Dall TM Mann SE The economic costs of undiagnosed diabetes Popul Health Manage 2009 12 95 101
   Web of Science ®Google Scholar
• Reilly MP Rader DJ The metabolic syndrome: more than the sum of its parts? Circulation 2003 108 1546 1551 14517150
   PubMed Web of Science ®Google Scholar
• Luscher TF Creager MA Beckman JA Cosentino F Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II Circulation 2003 108 1655 1661 14517152
   PubMed Web of Science ®Google Scholar
• LeRoith D Dyslipidemia and glucose dysregulation in overweight and obese patients Clin Cornerstone 2007 8 38 52 18452841
   PubMedGoogle Scholar
• Sattar N Wannamethee SG Forouhi NG Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? Diabetologia 2008 51 926 940 18392804
   PubMed Web of Science ®Google Scholar
• Haffner SM Insulin resistance, inflammation, and the prediabetic state Am J Cardiol 2003 92 18J 26J
   PubMed Web of Science ®Google Scholar
• Bidwell J Keen L Gallagher G Cytokine gene polymorphisms in human disease on-line database Gene Immun 1999 1 3 19
   PubMed Web of Science ®Google Scholar
• Bidwell J Keen L Gallagher G Cytokine gene polymorphisms in human disease on-line database, supplement 1 Gene Immun 2001 2 61 70
   PubMed Web of Science ®Google Scholar
• Haukim N Bidwell J Smith AJP Cytokine gene polymorphisms in human disease on-line database, supplement 2 Gene Immun 2002 3 313 330
   PubMed Web of Science ®Google Scholar
• Hollegaard MV Bidwell LJ Cytokine gene polymorphisms in human disease on-line database, supplement 3 Gene Immun 2006 2006 6364301
   Google Scholar
• Ollier WER Cytokine genes and disease susceptibility Cytokine 2004 28 174 178 15588692
   PubMed Web of Science ®Google Scholar
• Wannamethee SG Lowe GD Rumley A Cherry L Whincup PH Sattar N Adipokines and risk of type 2 diabetes in older men Diabetes Care 2007 30 1200 1205 17322479
   PubMed Web of Science ®Google Scholar
• Duncan BB Schmidt MI Pankow JS Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study Diabetes 2003 52 1799 1805 12829649
   PubMed Web of Science ®Google Scholar
• Hu FB Meigs JB Li TY Rifai N Manson JE Inflammatory markers and risk of developing type 2 diabetes in women Diabetes 2004 53 693 700 14988254
   PubMed Web of Science ®Google Scholar
• Spranger J Kroke A Mohlig M Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective populationbased European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study Diabetes 2003 52 812 817 12606524
   PubMed Web of Science ®Google Scholar
• Bastard JP Maachi M Lagathu C Recent advances in the relationship between obesity, inflammation and insulin resistance Eur Cytokine Network 2006 17 4 12
   PubMed Web of Science ®Google Scholar
• Vassalli P The pathophysiology of tumor necrosis factors Annu Rev Immunol 1992 10 411 452 1590993
   PubMed Web of Science ®Google Scholar
• Moller DE Potential role of TNF-a in the pathogenesis of insulin resistance and type 2 diabetes Trends Endocrinol Metab 2000 11 212 217 10878750
   PubMed Web of Science ®Google Scholar
• Pittas AG Lau J Hu FB Dawson-Hughes B Review: The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis J Clin Endocrinol Metabol 2007 92 2017 2029
   PubMed Web of Science ®Google Scholar
• Kubaszek SA Pihlajamaki J Komarovski V Finnish diabetes prevention study: promoter polymorphisms of the TNF-α (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish diabetes prevention study Diabetes 2003 52 1872 1876 12829659
   PubMed Web of Science ®Google Scholar
• Hoffstedt J Eriksson PHL Rossner S Ryden PAM Excessive fat accumulation is associated with the TNFα-308 G/A promoter polymorphism in women but not in men Diabetologia 2000 43 117 120 10672452
   PubMed Web of Science ®Google Scholar
• Susa S Daimon M Sakabe J A functional polymorphism of the TNF-alpha gene that is associated with type 2 DM Biochem Biophys Res Commun 2008 369 943 947 18328809
   PubMed Web of Science ®Google Scholar
• Rasmussen SK Urhammer SA Jensen JN Hansen T Borch- Johnsen K Pedersen O The −238 and −308 G>A polymorphisms of the tumor necrosis factor a gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians J Clin Endocrinol Metab 2000 85 1731 1734 10770222
   PubMed Web of Science ®Google Scholar
• Zeggini E Groves CJ Parkinson JR Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes Diabetologia 2005 48 2013 2017 16132956
   PubMed Web of Science ®Google Scholar
• Kroeger KM Carville KS Abraham LJ The −308 tumor necrosis factor-α promoter polymorphism effects transcription Mol Immunol 1997 34 391 399 9293772
   PubMed Web of Science ®Google Scholar
• Fong CL Siddiqui AH Mark DF Identification and characterization of a novel repressor site in the human tumor necrosis factor alpha gene Nucleic Acids Res 1994 22 1108 1114 8152914
   PubMed Web of Science ®Google Scholar
• Fried SK Bunkin DA Greenberg AS Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid J Clin Endocrinol Metab 1998 83 847 850 9506738
   PubMed Web of Science ®Google Scholar
• Fain JN Madan AK Hiler ML Cheema P Bahouth SW Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans Endocrinology 2004 145 2273 2282 14726444
   PubMed Web of Science ®Google Scholar
• Mohamed-Ali V Goodrick S Rawesh A Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo J Clin Endocrinol Metab 1997 82 4196 4200 9398739
   PubMed Web of Science ®Google Scholar
• Orban Z Remaley AT Sampson M Trajanoski Z Chrousos GP The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man J Clin Endocrinol Metab 1999 84 2126 2133 10372721
   PubMed Web of Science ®Google Scholar
• Sandler S Bendtzen K Eizirik DL Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro Endocrinology 1990 126 1288 1294 2404746
   PubMed Web of Science ®Google Scholar
• Bastard JP Maachi M Van Nhieu JT Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro J Clin Endocrinol Metab 2002 87 2084 2089 11994345
   PubMed Web of Science ®Google Scholar
• Maachi M Pieroni L Bruckert E Systemic low-grade inflammation is related to both circulating and adipose tissue TNFα, leptin and IL-6 levels in obese women Int J Obes Relat Metab Disord 2004 28 993 997 15211360
   PubMed Web of Science ®Google Scholar
• Bastard JP Jardel C Bruckert E Elevated levels of interleukin -6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss J Clin Endocrinol Metab 2000 85 3338 3342 10999830
   PubMed Web of Science ®Google Scholar
• Nonogaki K Fuller GM Fuentes NL Interleukin-6 stimulates hepatic triglyceride secretion in rats Endocrinology 1995 136 2143 2149 7720663
   PubMed Web of Science ®Google Scholar
• Yudkin JS Kumari M Humphries SE Mohamed-Ali V Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000 148 209 214 10657556
   PubMed Web of Science ®Google Scholar
• Grimble RF Inflammatory status and insulin resistance Curr Opin Clin Nutr Metab Care 2002 5 551 559 12172480
   PubMed Web of Science ®Google Scholar
• Ihle JN Witthuhn BA Quelle FW Yamamoto K Silvennoinen O Signaling through the hematopoietic cytokine receptors Annu Rev Immunol 1995 13 369 398 7612228
   PubMed Web of Science ®Google Scholar
• Kristiansen OP Mandrup-Poulsen T Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 2005 54 Suppl 2 S114 S124 16306329
   PubMed Web of Science ®Google Scholar
• Hirosumi J Tuncman G Chang L A central role for JNK in obesity and insulin resistance Nature 2002 420 333 336 12447443
   PubMed Web of Science ®Google Scholar
• Mooney RA Senn J Cameron S Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance J Biol Chem 2001 276 25889 25893 11342531
   PubMed Web of Science ®Google Scholar
• Lagathu C Bastard JP Auclair M Maachi M Capeau J Caron M Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone Biochem Biophys Res Commun 2003 311 372 379 14592424
   PubMed Web of Science ®Google Scholar
• Rieusset J Bouzakri K Chevillotte E Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients Diabetes 2004 53 2232 2241 15331532
   PubMed Web of Science ®Google Scholar
• Hundal RS Peterson KF Mayerson AB Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes J Clin Invest 2002 109 1321 1326 12021247
   PubMed Web of Science ®Google Scholar
• Huth C Heid IM Vollmert C IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants’ data from 21 studies Diabetes 2006 55 2915 2921 17003362
   PubMed Web of Science ®Google Scholar
• Gewurz H Zhang XH Lint TF Structure and function of the pentraxins Curr Opin Immunol 1995 7 54 64 7772283
   PubMed Web of Science ®Google Scholar
• Pearson TA Mensah GA Alexander RW Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 2003 107 499 511 12551878
   PubMed Web of Science ®Google Scholar
• Dehghan A Kardys I de Maat MP Genetic variation, C-reactive protein levels, and incidence of diabetes Diabetes 2007 56 872 878 17327459
   PubMed Web of Science ®Google Scholar
• Doi Y Kiyohara Y Kubo M Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study Diabetes Care 2005 28 2497 2500 16186286
   PubMed Web of Science ®Google Scholar
• Laaksonen DE Niskanen L Nyyssonen K C-reactive protein and the development of the metabolic syndrome and diabetes in middleaged men Diabetologia 2004 47 1403 1410 15309290
   PubMed Web of Science ®Google Scholar
• Nakanishi S Yamane K Kamei N Okubo M Kohno N Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans Diabetes Care 2003 26 2754 2757 14514575
   PubMed Web of Science ®Google Scholar
• Freeman DJ Norrie J Caslake MJ C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study Diabetes 2002 51 1596 1600 11978661
   PubMed Web of Science ®Google Scholar
• Barzilay JI Abraham L Heckbert SR The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study Diabetes 2001 50 2384 2389 11574423
   PubMed Web of Science ®Google Scholar
• Krakoff J Funahashi T Stehouwer CD Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian Diabetes Care 2003 26 1745 1751 12766104
   PubMed Web of Science ®Google Scholar
• Lee CC Adler AI Sandhu MS Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis Diabetologia 2009 52 1040 1047 19326095
   PubMed Web of Science ®Google Scholar
• Anan F Takahashi N Nakagawa M Ooie T Saikawa T Yoshimatsu H High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients Metabolism 2005 54 552 558 15798966
   PubMed Web of Science ®Google Scholar
• Pfutzner A Standl E Strotmann HJ Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus Clin Chem Lab Med 2006 44 556 560 16681424
   PubMed Web of Science ®Google Scholar
• Nabata A Kuroki M Ueba H C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: Implications for the destabilization of atherosclerotic plaque Atherosclerosis 2008 196 129 135 17531242
   PubMed Web of Science ®Google Scholar
• Hage FG Szalai AJ C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk J Am Coll Cardiol 2007 50 1115 1122 17868801
   PubMed Web of Science ®Google Scholar
• Obisesan TO Leeuwenburgh C Ferrell RE C-reactive protein genotype affects exercise training-induced changes in insulin sensitivity Metabolism 2006 55 453 460 16546475
   PubMed Web of Science ®Google Scholar
• Wolford JK Gruber JD Ossowski VM A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians Mol Genet Metab 2003 78 136 144 12618085
   PubMed Web of Science ®Google Scholar
• Zee RY Germer S Thomas A C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study Atherosclerosis 2008 197 931 936 17900590
   PubMed Web of Science ®Google Scholar
• Lange LA Burdon K Langefeld CD Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study Ann Hum Genet 2006 70 717 725 17044846
   PubMed Web of Science ®Google Scholar
• Grammer TB Marz W Renenr W Bohm BO Hoffmann MM C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study Eur Heart J 2009 30 170 182 18499652
   PubMed Web of Science ®Google Scholar
• Kushner I Jiang SL Zhang D Lozanski G Samols D Do posttranscriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1? Ann N Y Acad Sci 1995 762 102 107 7668521
   PubMed Web of Science ®Google Scholar
• Vickers MA Green FR Terry C Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein Cardiovasc Res 2002 53 1029 1034 11922913
   PubMed Web of Science ®Google Scholar
• Libra M Signorelli SS Bevelacqua Y Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease J Clin Pathol 2006 59 211 215 16443741
   PubMed Web of Science ®Google Scholar
• Paik JK Kim OY Koh SJ Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors Clin Chim Acta 2007 380 68 74 17335789
   PubMed Web of Science ®Google Scholar
• Rendell M The role of sulphonylureas in the management of type 2 diabetes mellitus Drugs 2004 64 1339 1358 15200348
   PubMed Web of Science ®Google Scholar
• Kirpichnikov D McFarlane SI Sowers JR Metformin: An update Ann Intern Med 2002 137 25 33 12093242
   PubMed Web of Science ®Google Scholar
• Krentz AJ Bailey CJ Oral antidiabetic agents: Current role in type 2 diabetes mellitus Drugs 2005 65 385 411 15669880
   PubMed Web of Science ®Google Scholar
• Delerive P Fruchart JC Staels B Peroxisome proliferator-activated receptors in inflammation control J Endocrinol 2001 169 453 459 11375115
   PubMed Web of Science ®Google Scholar
• Fukuzawa M Satoh J Qiang X Inhibition of tumor necrosis factor-alpha with anti-diabetic agents Diabetes Res Clin Pract 1999 43 147 154 10369423
   PubMed Web of Science ®Google Scholar
• Shoelson SE Lee M Yuan M Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance Int J Obes Related Metab Disord 2003 27 Suppl 3 S49 S52
   PubMed Web of Science ®Google Scholar
• Robertson RP Prostaglandins as modulators of pancreatic islet function Diabetes 1979 28 942 948 383557
   PubMed Web of Science ®Google Scholar
• Robertson RP Arachidonic acid metabolism, the endocrine pancreas, and diabetes mellitus Pharmacol Ther 1984 24 91 106 6427797
   PubMed Web of Science ®Google Scholar
• Maggini S Wintergerst ES Beveridge S Hornig DH Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses Br J Nutr 2007 98 Suppl 1 S29 S35 17922955
   PubMed Web of Science ®Google Scholar
• Pittas AG Dawson-Hughes B Li T Vitamin D and calcium intake in relation to type 2 diabetes in women Diabetes Care 2006 29 650 656 16505521
   PubMed Web of Science ®Google Scholar
• Haddad PS Azar GA Groom S Boivin M Natural health products, modulation of immune function and prevention of chronic diseases. Evid Based Complement Alternat Med 2005 2 513 520
   Google Scholar
• Holick MF Vitamin D: a D-Lightful health perspective Nutr Rev 2008 66 Suppl 2 S182 S194 18844847
   PubMed Web of Science ®Google Scholar
• Holick MF Diabetes and the vitamin D connection Curr Diabetes Rep 2008 8 393 398
   PubMed Web of Science ®Google Scholar
• Fu L Yun F Oczak M Wong BYL Veith R Cole DEC Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation Clin Biochem 2009 42 1174 1177 19302999
   PubMed Web of Science ®Google Scholar
• Hirai M Suzuki S Hinokio Y Variation in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance J Clin Endocrinol Metab 2000 85 1951 1953 10843180
   PubMed Web of Science ®Google Scholar
• Bair LJ Dobberfuhl AM Pratley RE Hanson RL Bogardus C Variation in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians J Clin Endocrinol Metab 1998 83 2993 2996 9709981
   PubMed Web of Science ®Google Scholar
• Szathmary EJ The effect of Gc genotype on fasting insulin level in Dogrib Indians Hum Genet 1987 75 368 372 3552957
   PubMed Web of Science ®Google Scholar
• Hayes CE Nashold FE Spach KM Pedersen LB The immunological functions of the vitamin D endocrine system Cell Mol Biol 2003 49 277 300 12887108
   PubMed Web of Science ®Google Scholar
• Griffin MD Xing N Kumar R Vitamin D and its analogs as regulators of immune activities and antigen presentation Annu Rev Nutr 2003 23 117 145 12651965
   PubMed Web of Science ®Google Scholar
• Cantorna MT Zhu Y Froicu M Wittke A Vitamin D status, 1,25-dihydroxy-vitamin D3, and the immune system Am J Clin Nutr 2004 80 1717S 1720S 15585793
   PubMed Web of Science ®Google Scholar
• Veldman CM Cantorna MT DeLuca HF Expression of 1,25- dihydroxyvitamin D3 receptor in the immune system Arch Biochem Biophys 2000 374 334 338 10666315
   PubMed Web of Science ®Google Scholar
• DeLuca HF Cantorna MT Vitamin D: its role and uses in immunology FASEB J 2001 15 2579 2585 11726533
   PubMed Web of Science ®Google Scholar
• van Etten E Mathieu C Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts J Steroid Biochem Mol Biol 2005 97 93 101 16046118
   PubMed Web of Science ®Google Scholar
• Han SN Adolfsson O Lee CK Prolla TA Ordovas J Meydani SN Vitamin E and gene expression in immune cells Ann N Y Acad Sci 2004 1031 96 101 15753137
   PubMed Web of Science ®Google Scholar
• Adolfsson O Huber BT Meydani SN Vitamin E-enhanced IL-2 production in old mice: naive but not memory T cells show increased cell division cycling and IL-2 -producing capacity J Immunol 2001 167 3809 3817 11564798
   PubMed Web of Science ®Google Scholar
• Singh U Jialal I Anti-inflammatory effects of α-tocopherol Ann N Y Acad Sci 2004 1031 195 203 15753145
   PubMed Web of Science ®Google Scholar
• Devaraj JS Jialal I Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase Arterioscler Thromb Vasc Biol 1999 19 1125 1133 10195945
   PubMed Web of Science ®Google Scholar
• Scott JA King GL Oxidative stress and antioxidant treatment in diabetes Ann N Y Acad Sci 2004 1031 204 213 15753146
   PubMed Web of Science ®Google Scholar
• Thomas SR Stocker R Molecular action of vitamin E in lipoprotein oxidation: Implications for athrosclerosis Free Radic Biol Med 2000 28 1795 1805 10946221
   PubMed Web of Science ®Google Scholar
• Ristow M Zarse K Oberbach A Antioxidants prevent healthpromoting effects of physical exercise in humans Proc Natl Acad Sci U S A 2009 106 8665 8670 19433800
   PubMed Web of Science ®Google Scholar
• Buijsee B Feskens EJM Kwape L Kok FJ Kormhout D Both alphaand beta-carotene, but not tocopherols and vitamin C, are inversely related to 15-year cardiovascular mortality in Dutch elderly men J Nutr 2008 138 344 350 18203902
   PubMed Web of Science ®Google Scholar